Clinical Trials Logo

Otitis clinical trials

View clinical trials related to Otitis.

Filter by:

NCT ID: NCT05348291 Recruiting - Clinical trials for Recurrent Acute Otitis Media

Effect of Ventilation Tubes in Otitis-prone Children

Start date: October 21, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of ventilation tubes in children with recurrent ear infections. By drawing lots, young children with recurrent ear infections will be assigned to one of two groups (ventilation tubes or close follow-up), and the number of ear infections and antibiotic prescriptions in each group will be monitored. The study participants will be followed until they are 7 years old.

NCT ID: NCT05324696 Recruiting - Hearing Loss Clinical Trials

Autoinflation: Alternative in the Treatment of Otitis Media With Effusion

OME
Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Otitis media with effusion (OME) is a common finding affecting children and the main cause of acquired hearing loss in the pediatric age. OBJECTIVES The purpose of the clinical study is to determine whether self-inflation using a new device: - It is an effective non-invasive treatment during the watchful waiting period, with the ability to improve hearing loss and prevent surgical treatment; - Maintains long-term hearing improvement;

NCT ID: NCT05133258 Completed - Clinical trials for Chronic Suppurative Otitis Media

Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media

Start date: July 5, 2022
Phase:
Study type: Observational

The study team aims to elucidate the potential role of ototopical antibiotic concentration on outcomes in patients diagnosed with chronic suppurative otitis media (CSOM). Chronic suppurative otitis media (CSOM) is characterized by chronic inflammation of the middle ear with persistent discharge from a non-intact tympanic membrane. CSOM is notably associated with a significant burden of disease worldwide. Topical fluoroquinolones are first line therapy for CSOM and are advantageous as compared to oral or intravenous therapy in that these antibiotics avoid systemic side effects and have the potential to locally deliver high antibiotic concentrations, which were thought to be sufficient to overcome all bactericidal resistance to fluoroquinolones. The investigators will measure antibiotic concentration in aspirates via liquid chromatography with tandem mass spectrometry (LC-MS/MS) from the middle ear of selected subjects with CSOM who are prescribed and instructed to self-administer ototopical ciprofloxacin. Enrolled subjects will be asked to return 3 to 10 days after initial visit to aspirate the middle ear and receive a follow-up evaluation. Furthermore, the subjects will be asked to keep logs of their medication use and to administer the ototopical medication one hour prior to their appointments. The measured ciprofloxacin concentrations will be correlated with clinical outcomes, primarily the time to symptom resolution. The guiding hypothesis is that patient self-administration of ciprofloxacin drops vary in antibiotic delivery with diluted concentrations significantly below the in vitro concentration of the prescribed solution and that these concentrations are below the bactericidal concentration of ciprofloxacin-resistant bacteria.

NCT ID: NCT04950985 Active, not recruiting - Clinical trials for Necrotising Otitis Externa

Improving Outcomes of Necrotising Otitis Externa

IONOE
Start date: August 20, 2021
Phase:
Study type: Observational

A UK multi-centre prospective observational study of clinically possible cases of NOE.

NCT ID: NCT04946084 Active, not recruiting - Acute Otitis Media Clinical Trials

Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

AOM
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The investigators seek to conduct a prospective, longitudinal study to identify the dynamic changes in nasopharyngeal (NP) colonization patterns and acute otitis media (AOM) etiology involving antibiotic-resistant Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu).

NCT ID: NCT04864912 Completed - Clinical trials for Chronic Otitis Media

Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery

Start date: February 1, 2022
Phase:
Study type: Observational

The objective of this multicentre study is to evaluate the standard of care of participants diagnosed with Chronic Otitis Media that have already gone through a first middle ear surgery but still have at least a moderate hearing loss. The study has a retrospective part (extraction of medical chart data) and a prospective part with a survey and three questionnaires collecting data on the use of health care services, on health related quality of life and hearing performance.

NCT ID: NCT04812093 Recruiting - Clinical trials for Middle Ear Infection

Spectroscopic Evaluation of Middle Ear Infection

Start date: February 26, 2021
Phase:
Study type: Observational

Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical procedure. Despite this a high degree of inaccuracy exists in diagnosis of this condition which depends on subjective assessment of the ear drum via direct visualization using an otoscope. Researchers can use LED-based multi wavelength light absorption and scattering measurements for the analysis of ear drum and the middle ear.

NCT ID: NCT04761562 Recruiting - Clinical trials for Tympanic Membrane Perforation

Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections

Start date: February 14, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma as a supplement to the surgical treatment of chronic tympanic membrane perforations. Half of the participants will be treated with standard surgical procedure called tympanoplasty and addition of platelet- and extracellular vesicle-rich plasma. Another half will be treated with only the standard tympanoplasty.

NCT ID: NCT04752891 Completed - Clinical trials for Otitis Media, Suppurative

Assessment of an App Based on Artificial Intelligence for Purulent AOM Diagnosis in a Pediatric Department

OMA-IA
Start date: June 10, 2021
Phase: N/A
Study type: Interventional

Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in developed countries . An artificial intelligence-based tool could help physicians refine their diagnosis

NCT ID: NCT04743609 Recruiting - Pneumonia Clinical Trials

RSV Burden in Outpatient Settings

Oursyn
Start date: February 8, 2021
Phase:
Study type: Observational

Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)